# Tyra Biosciences Inc. (TYRA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $28.65, market value $1.7 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Tyra Biosciences Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 4.8×**. The shares trade at 4.8× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -6.4%** (5-yr avg -10.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -46.3%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): -33.1%**. Earnings per share fell 33.1%.

## Financial health
- **Current ratio: 14.67** (quick 14.67). Current assets cover the next year's liabilities 14.67 times.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Tyra Biosciences Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (11 analysts). 11 analysts cover Tyra Biosciences Inc.; the consensus is strong_buy, with an average price target of $50.82 (+77% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 136.0%** (YTD 9.0%, 3-mo 7.5%). The shares are up 136.0% over twelve months including dividends.
- **From 52-week high: -29.5%** (144.8% above the low). Trading 30% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 58**. An RSI of 58 is neutral.
- **Beta (1 yr): 0.54** (volatility 63%). Beta of 0.54 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TYRA · Page: https://foliofundamentals.com/stocks/tyra

Not investment advice.